Important Statement
According to the regulations of the Basic Norms for Enterprise Internal Control and its supporting guidelines, as well as other internal control regulatory requirements, combined with the actual operating conditions and environment of China Resources Biopharma Group Co., Ltd. (hereinafter referred to as "the Company"), the board of directors conducted a comprehensive examination and evaluation of the design and execution effectiveness of the internal control system as of December 31, 2025 (the benchmark date for the internal control evaluation report) to promote the Company's long-term sustainable development and comprehensively improve management levels and risk control capabilities.
The establishment, improvement, and effective implementation of internal control, as well as the truthful disclosure of the internal control evaluation report, are the responsibilities of the Company's board of directors. The audit committee supervises the establishment and implementation of internal control by the board. The management is responsible for organizing and leading the daily operation of internal control. The Company's board of directors, audit committee, and directors and senior management ensure that the content of this report does not contain any false records, misleading statements, or significant omissions, and bear individual and joint legal responsibility for the truthfulness, accuracy, and completeness of the report content.
The goal of the Company's internal control is to reasonably ensure that business management is legal and compliant, assets are secure, financial reporting and related information are true and complete, operational efficiency and effectiveness are improved, and development strategies are achieved. Due to the inherent limitations of internal control, it can only provide reasonable assurance for achieving the above goals. Additionally, changes in circumstances may lead to internal control becoming inappropriate or a decrease in adherence to control policies and procedures, making it risky to infer the future effectiveness of internal control based on evaluation results.
Internal Control Evaluation Conclusion
According to the identification of significant defects in internal control over financial reporting, as of the benchmark date of the internal control evaluation report, the Company has no significant or important defects in internal control over financial reporting. The board believes that the Company has maintained effective internal control over financial reporting in all significant aspects in accordance with the requirements of the enterprise internal control normative system and related regulations. Based on the identification of significant defects in non-financial reporting internal control, as of the benchmark date of the internal control evaluation report, the Company has no significant or important defects in non-financial reporting internal control.
No factors affecting the evaluation conclusion of internal control effectiveness have occurred between the benchmark date of the internal control evaluation report and the issuance date of the internal control evaluation report.